Corporate Ventures Fund of Merck KGaA, Darmstadt, Germany, Creates New Immuno-Oncology Company iOnctura June 20, 2017July 11, 2017 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: SPT Labtech announces acquisition by EQT Private…Roche enters partnership with the Global Fund to…Illumina Invests in £30M Venture Fund to Advance…Danaher to Provide Cepheid's Tuberculosis Test…Azenta, Inc. (Nasdaq: AZTA) Announces Completion of…[Delayed] Corporate Governance Report
